The U.S. health regulator expanded the emergency use authorization for Eli Lilly's baricitinib for Covid-19, saying the arthritis medicine could now be used without taking Gilead's...
Cell and gene therapies (C&GTs) present opportunities to not only treat disease, but to restore function and improve disease management. Although the opportunities with C&GTs are...
Not as much as you might think. The Food and Drug Administration claims to follow the science. So why is it attacking ivermectin, a medication it...
The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific...
In the face of a crisis situation, it is a given that the clarity and thoroughness of the communications response is key to resolving the issue...
Should investors be focusing on health care stocks as coronavirus fears escalate? The post Top Health Care Stocks To Buy Now? 4 For Your Watchlist appeared...
Why These Reopening Penny Stocks Could Benefit The Most In The Coming Weeks The post Top Reopening Penny Stocks to Buy in August 2021? 3 to...
Which marijuana penny stocks are investors watching after Tilray's spike today? The post Why Weed Penny Stocks Are Up Today & 3 to Watch as Tilray...
Vaccines can’t provide 100% protection, so it’s not a failure or surprise when some vaccinated people get sick with COVID-19. The good news is their cases...
The company's digital therapy platform works to measure and improve someone’s ability to walk after they have experienced a neurologic injury or disease.
Best biotech penny stocks on Robinhood? Check these 3 out The post 3 Penny Stocks on Robinhood to Watch if You Like Biotech appeared first on...
The FDA has approved GlaxoSmithKline’s shingles vaccine Shingrix for use in people aged under 50 who are immunocompromised The post GSK wants to double Shingrix sales,...
A week after it was reported that India’s Covid-19 death toll could be in the millions, antibody legend Tillman Gerngross has inked a deal to develop...
The U.S. Food and Drug Administration issued Incyte Corporation with a Complete Response Letter (CRL) over the company's Biologics License Application (BLA) for retifanlimab for anal cancer.
Moderna Inc. is in talks with U.S. regulators to expand the size of an ongoing trial testing the company's Covid-19 vaccines in children aged between 5...
Yes, that’s a sort of oxymoron. So let me put it this way. Put more weight on an expert’s opinion than a non-expert’s opinion. But also...
Once vetted by the Biden team to lead the FDA as commissioner, Luciana Borio is now compiling quite the résumé. Borio has now been named a...
Why Is The CDC Quietly Abandoning The PCR Test For COVID? We have detailed (most recently here and here) the controversy surrounding America's COVID "casedemic" and...
Antimicrobial resistance could 'undermine ... care as we know it,' a leading infectious disease doctor tells TheStreet.
Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's Covid-19 vaccine, the benefits of its use outweigh the...
The U.S. FDA approved AstraZeneca's convenient once-a-week glucose-lowering drug Bydureon for 10- to 17-year-olds with type 2 diabetes. According to a study conducted in Canada, one...
Simona King → Back in May, Passage Bio CFO Richard Morris and CMO Gary Romano left within days of each other, but this week the gene...
Israel Finds Pfizer Jab Only 39% Effective At Stopping Delta Variant Over the past month, Israel, the world's most heavily vaccinated country (with leading mRNA jabs,...
PCT Ltd (OTCMKTS: PCTL) is making a powerhouse move up the charts after reversing off support levels just over the $0.01 mark. The stock has a...
Congenica CEO David Atkins recently took time to chat with Clinical OMICs Editor in Chief Chris Anderson about the company’s plans and his views of the...
As coronavirus fears run high, are these health care stocks taking center stage? The post 5 Top Health Care Stocks To Watch Ahead Of August 2021...
Switzerland-based Roche is in talks with the U.S. Food and Drug Administration over the company's Alzheimer’s drug candidate gantenerumab, which is being evaluated in clinical studies with a large-scale Phase III...
Almost five years after Seres Therapeutics slammed into a Phase II failure with its lead candidate, the microbiome pioneer is reporting another massive flop in ulcerative...
Investments in digital health firms are running high at the moment, and a $90 million round for four-year-old The post Digital mental health specialist Woebot raises...
Happify Health has launched a prescription digital therapeutic (DTx) – called Ensemble – that can assist the treatment The post Happify launches Ensemble DTx for depression,...